Agilent Technologies, Inc. - Diagnostics and Genomics SS Tumor Map Assay Probes, DNA+RNA, 96
The Agilent SureSelect Tumor MAP Probes, DNA+RNA, 96 (part number 5191-6991) are designed for use with the SureSelect platform to enable comprehensive profiling of tumor samples. These probes facilitate the simultaneous capture and enrichment of both DNA and RNA targets from formalin-fixed, paraffin-embedded (FFPE) or fresh frozen tissue samples. The kit supports high-throughput analysis, allowing for the detection of a wide range of genomic alterations, including mutations, fusions, and expression changes relevant to cancer research. The 96-reaction format is optimized for streamlined workflow and scalability in clinical research and translational genomics laboratories.
